Recent Headlines
Monoclonal antibody treatment is now available to COVID-19 patients, but only about 30% of the delivered doses have been administered.
-
Coronavirus mutations are on the rise. The longer it takes to vaccinate people, the more likely we’ll see a variant that eludes our tests, treatments and vaccines.
-
The test strip will help determine whether the wearer has the coronavirus or has been exposed to it.
-
U.S. regulators have approved the first long-acting drug combination for HIV, monthly shots that can replace daily pills.
Nearly half of the 245 infections involve students living on campus.
Health officials set aside carefully considered plans for rolling out COVID-19 vaccines and made the shots widely available. That may hasten the pandemic’s end.
Many teachers, grocers and even some hospital employees are wary of the COVID-19 vaccine and don’t want it. The question of mandatory vaccine requirements by employers is complicated.
In an early safety study, Johnson & Johnson’s one-shot COVID-19 vaccine produced immune proteins in more than 90% of participants.
An ongoing study suggests older Americans are showing resilience and perseverance despite struggles with loneliness and isolation amid the pandemic.
More Americans are now eligible to get a COVID-19 vaccine, but they may still have to wait for their first shot even as supplies increase. Here’s a closer look.
Children who spread coronavirus to their parents and grandparents are apologizing to them on their deathbeds as L.A. County reels.
More Coverage
The coronavirus strain from the U.K. is now in at least nine U.S. states. Given its ability to spread, scientists expect that number to rise soon.
Health news, ideas, advice and commentary.
Most Read
-
Researchers share which numbers they’re watching to forecast when California’s deadly COVID-19 surge will end.
-
If the COVID-19 vaccine from Pfizer and BioNTech was good enough to get a nod from the FDA, the vaccine from Moderna and the NIH almost certainly is as well.
-
A lot of things are different when you’re in the midst of a global pandemic. A case in point: How federal regulators scrutinize and authorize new vaccines.
The demand for oxygen has skyrocketed, as critically ill COVID-19 patients often need high rates of oxygen flowing into their lungs to keep them alive.
Five of the highest single-day death tallies for California have been recorded in the last week.
British scientists have bolstered their case that the new coronavirus variant spreads more easily than its predecessors. It could be worse in the U.S., they warn.
With hospital morgues and funeral homes full and deaths mounting, California struggles to store the bodies of COVID-19 victims.
More Coverage
On Thursday and Friday, L.A. County reported 18,764 coronavirus cases and 17,827 cases, respectively, significantly above the average of last week.
New research suggests that Pfizer-BioNTech’s COVID-19 vaccine can work against the coronavirus variant first detected and now rampant in Britain.
The COVID-19 vaccines in the U.S. require two shots taken weeks apart, and you’ll be given a record card so you’ll know when to return for the second dose.
Severe allergic reactions to Pfizer’s COVID-19 vaccine were rare in the first 10 days of its rollout, with 21 cases among nearly 1.9 doses, the CDC reported.
Fresno County hospitals scramble for oxygen machines to treat COVID patients at home, with few ICU beds available. Mortuaries work to maximize space.
Covid-19 Vaccines
Mayor Eric Garcetti says he’s confident manufacturers will meet demand and additional COVID vaccines will be approved. But many more doses are needed.
-
Tens of thousands of people face confusion, contradiction and chaos amid the state’s uneven vaccine rollout.
-
As millions pine for their COVID-19 vaccinations, a lucky few are getting bumped to the front of the line because of extra doses that must get used.
-
David Halls isn’t a doctor, nurse or ambulance driver, but he wanted to contribute in the fight against COVID-19 in Britain.
-
In a letter to President Biden, Amazon offers ‘to leverage our operations, information technology and communications’ to help with COVID vaccines.
-
Gov. Gavin Newsom said 1 million additional doses of COVID-19 vaccine would be administered in California over the course of 10 days. But due to the state’s data collection issues, it is unclear whether he met that goal.
More headlines
-
A new study shows that differences in the DNA of identical twins can show up within the first two weeks after an egg is fertilized.
-
Hank Aaron, Andrew Young and other ‘trusted messengers’ get their COVID-19 vaccines, hoping to convey to Black America that the shots are safe.
-
Dorr, a surgeon who led early developments in joint replacement surgery and founded a charity to provide medical services pro bono, has died at 79.
-
U.S. experts have calculated the riskiest and safest counties in the country for natural disasters, and Los Angeles is on the shakiest ground.
-
Workplaces remain an area of growing concern, amid new outbreaks at retail establishments as well as other businesses deemed essential.
-
A bleak new threshhold of 350,000 deaths is reached. Despite Trump’s claims, Fauci says the toll ‘not fake.’
-
Officials are investigating whether the outbreak was affected by a staff member appearing in the emergency department on Christmas Day wearing an air-powered, holiday-themed costume.
-
Los Angeles County posted its third highest single-day total for coronavirus cases on New Year’s Day
-
Some residents of Mexico City are spending New Year’s Day in lines waiting to refill oxygen canisters for relatives suffering from COVID-19.
-
A veteran critical care nurse in northern Greece didn’t feel good about the treatment options available when his wife, both her parents and her brother got COVID-19 in alarming succession.
-
The first reported U.S. case of COVID-19 caused by the variant was detected in Colorado, and a second case was reported in San Diego.
Get our free Coronavirus Today newsletter
Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.
You may occasionally receive promotional content from the Los Angeles Times.